Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
-
Available for purchase today at Stelo.com for people in the
U.S. 18 and older not using insulin - Provides 24/7 powerful and personalized glucose insights directly to a smartphone,* revealing how food, exercise and sleep can affect glucose
- Tracking glucose just got easier, with no prescription and no fingersticks, ever
- Specifically designed to help people with Type 2 diabetes not using insulin and those with prediabetes reach their A1c goals and potentially slow the progression of diabetes. †,1-3
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240826019839/en/
Stelo is designed to help people with Type 2 diabetes not using insulin and those with prediabetes. (Photo:
Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate glucose sensing technology.5 It is specifically designed to provide the 125 million Americans6 with Type 2 diabetes not using insulin and those withprediabetes with powerful, personalized glucose insights sent directly to a smartphone,* revealing how food, exercise and sleep can affect glucose – all without painful fingersticks.
“Dexcom has been at the forefront of glucose biosensing for 25 years. With the launch of Stelo, we’re defining a brand-new category and once again setting the gold standard for people to easily take control of their health,” said
The benefits of glucose biosensing have been shown when used alone, or alongside other diabetes and weight management medications.7 Studies show the use of
“Dexcom glucose biosensors are an essential and proven tool for diabetes management – driving strong clinical outcomes regardless of medication use9 and even potentially slowing the progression of diabetes,†,1-3” said
Key features of Stelo
- No fingersticks, ever: The only over-the-counter glucose biosensor designed for people with diabetes that doesn’t require any fingersticks.
- Up to 15-day wear time ‡ and waterproof §: The longest biosensor wear time on the market‡with the highest waterproof rating.
- A personalized, easy-to-use app4: Provides daily, weekly and session summary insights that can help form healthier habits.
- Spike and pattern detection4: The only over-the-counter glucose biosensor for people with diabetes featuring spike detection, designed to identify meaningful glucose variability as it happens so users can make informed changes.
-
Proven results with
Dexcom glucose sensors †: Using Dexcom glucose sensors like Stelo helps lower A1c†,1,10, 13-19 for people with Type 2 diabetes and may help slow the progression of diabetes.†,1-3 OnlyDexcom glucose sensors have been associated with significant improvements in glucose and cardiovascular risk reduction measures as early as three months.||,13
Effortless ordering, delivered directly to your door
Stelo improves access to critical health technology for people with Type 2 diabetes not using insulin and those withprediabetes who might not have insurance coverage for prescription glucose biosensors. Stelo is currently available for purchase in the
-
Pay-as-you-go: Pay
$99 for a single pack of two sensors (total wear time up to 30 days‡). -
Monthly subscription: Subscribe and save 10%. Pay
$89 per month for an ongoing subscription, with two sensors (total wear time up to 30 days‡) delivered every 30 days.
Stelo is now part of Dexcom’s overall portfolio of glucose biosensors, with a user base of more than 2.5 million people globally. The
Each product in the portfolio is built for the people who use them, making it easier than ever for healthcare providers to get patients started with the glucose biosensor best for them. Dexcom G6 and Dexcom G7 are designed for people with diabetes using insulin or who are at risk of hypoglycemia and who have insurance coverage for glucose biosensors. Both systems require a prescription and are reimbursed by 97% of commercial insurers in the
Visit Stelo.com today to get started with Stelo, or do a benefits check to see if you are eligible for Dexcom G7 at Dexcom.com/Start .
About
*Smart device sold separately. For Stelo app compatibility information, visit stelo.com/compatibility. †Results obtained from previous
1
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
Category: IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20240826019839/en/
Media Contact
619-884-2118
james.mcintosh@dexcom.com
Investor Contact
858-203-6657
sean.christensen@dexcom.com
Source: